- Home
- JBDI vs BNGO Comparison
JBDI vs BNGO Comparison
Compare JBDI & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JBDI
- BNGO
- Stock Information
- Founded
- JBDI 1983
- BNGO 2003
- Country
- JBDI Singapore
- BNGO United States
- Employees
- JBDI N/A
- BNGO N/A
- Industry
- JBDI
- BNGO Biotechnology: Laboratory Analytical Instruments
- Sector
- JBDI
- BNGO Industrials
- Exchange
- JBDI Nasdaq
- BNGO Nasdaq
- Market Cap
- JBDI 28.7M
- BNGO 24.3M
- IPO Year
- JBDI 2024
- BNGO 2018
- Fundamental
- Price
- JBDI $1.85
- BNGO $1.71
- Analyst Decision
- JBDI
- BNGO Buy
- Analyst Count
- JBDI 0
- BNGO 4
- Target Price
- JBDI N/A
- BNGO $7.67
- AVG Volume (30 Days)
- JBDI 4.1M
- BNGO 1.4M
- Earning Date
- JBDI 01-01-0001
- BNGO 11-12-2025
- Dividend Yield
- JBDI N/A
- BNGO N/A
- EPS Growth
- JBDI N/A
- BNGO N/A
- EPS
- JBDI N/A
- BNGO N/A
- Revenue
- JBDI $9,017,000.00
- BNGO $27,426,000.00
- Revenue This Year
- JBDI N/A
- BNGO N/A
- Revenue Next Year
- JBDI N/A
- BNGO $24.54
- P/E Ratio
- JBDI N/A
- BNGO N/A
- Revenue Growth
- JBDI N/A
- BNGO N/A
- 52 Week Low
- JBDI $0.49
- BNGO $1.50
- 52 Week High
- JBDI $3.00
- BNGO $28.80
- Technical
- Relative Strength Index (RSI)
- JBDI 57.59
- BNGO 31.04
- Support Level
- JBDI $1.37
- BNGO $1.67
- Resistance Level
- JBDI $2.15
- BNGO $1.85
- Average True Range (ATR)
- JBDI 0.37
- BNGO 0.34
- MACD
- JBDI 0.00
- BNGO -0.14
- Stochastic Oscillator
- JBDI 29.45
- BNGO 5.25
About JBDI JBDI Holdings Limited Ordinary Shares
JBDI Holdings Ltd is a supplier of Reconditioned and new Containers in Singapore. Its products include Reconditioned and new steel drums, plastic drums, carboys and IBCs.
About BNGO Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.